InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by KEATING LAURIE, Vice-Présidente Exécutive et Responsable Juridique. Insider active across 3 companies, notably ALNYLAM PHARMACEUTICALS, INC.. In total, 9 filings have been published. Total volume traded: €649k. The latest transaction was filed on 16 May 2022 — Acquisition. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
€33,5287,000 shares@ €4.78970.010% mcap15.9% of flow
Class A Common Stock
SEC:0001415889-22-005150:0·
Ideal exit: 10 Feb 2023 (T+270)
€591,9127,876 shares@ €75.15390.0015% mcap62.9% of flow
Common Stock
SEC:0001735276-21-000079·
€591,9127,876 shares@ €75.15390.0015% mcap31.5% of flow
Common Stock
SEC:0001735276-21-000079:0·
€88,4627,000 shares@ €12.63750.026% mcap100.0% of flow
Class A Common Stock
SEC:0001104659-21-099736·
Ideal exit: 30 Apr 2022 (T+270)
€88,4627,000 shares@ €12.63750.026% mcap42.0% of flow
Class A Common Stock
SEC:0001104659-21-099736:0·
Ideal exit: 30 Apr 2022 (T+270)
€129,8081,812 shares@ €71.6380.0003% mcap13.8% of flow
Common Stock
SEC:0001735276-21-000053·
€129,8081,812 shares@ €71.6380.0003% mcap6.9% of flow
Common Stock
SEC:0001735276-21-000053:0·
€219,2051,734 shares@ €126.4160.0006% mcap23.3% of flow
Common Stock
SEC:0001735276-21-000047·
€219,2051,734 shares@ €126.4160.0006% mcap11.6% of flow
Common Stock
SEC:0001735276-21-000047:0·
9 of 9 declarations
About KEATING LAURIE
Laurie Keating is the EVP, Chief Legal Officer at ALNYLAM PHARMACEUTICALS, INC., Immuneering Corp, and ALNYLAM PHARMACEUTICALS, INC. She brings expertise in business law and corporate governance. In her role, Laurie is responsible for legal strategy and compliance within the companies.
